1. Amotosalen‐HCl‐UVA pathogen reduction does not alter poststorage metabolism of soluble CD40 ligand, Ox40 ligand and interkeukin‐27, the cytokines that generally associate with serious adverse events. Issue 2 (21st October 2014) Authors: Hamzeh‐Cognasse, H.; Laradi, S.; Osselaer, J. C.; Cognasse, F.; Garraud, O. Journal: Vox sanguinis Issue: Volume 108:Issue 2(2015) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. How can non‐nucleated platelets be so smart?. (16th February 2016) Authors: Cognasse, F.; Garraud, O.; Pozzetto, B.; Laradi, S.; Hamzeh‐Cognasse, H. Journal: Journal of thrombosis and haemostasis Issue: Volume 14:Number 4(2016:Apr.) Page Start: 794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Paths to Understand and to Limit Inflammation in Transfusions. (January 2014) Authors: Garraud, O.; Hamzeh-Cognasse, H.; Laradi, S.; Cognasse, F. Journal: European journal of inflammation Issue: Volume 12:Number 1(2014) Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗